Filing Flows › Omega Healthcare Investors (OHI) › Q3 2026 › vs Q3 2025
Omega Healthcare Investors (OHI) Q3 2026 vs Q3 2025 (year over year)
Omega Healthcare Investors's revenue rose $29.0M (+9%) from $312M in Q3 2025 to $341M in Q3 2026. Operating margin 97.4% against 99.6% (-2.2 pts).
Omega Healthcare Investors, Q3 2026: revenue $341M (+9% year over year), operating margin 97.4%, net earnings $83.1M, operating cash flow $191M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 97.4% | 99.6% | -2.2 pts |
| Net margin | 24.4% | 57.7% | -33.3 pts |
| Free cash flow margin | 48.9% | 65.9% | -17.1 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $341M | $312M | $29.0M | +9% |
| Operating profit | $332M | $310M | $21.4M | +7% |
| Costs & expenses | $8.9M | $1.3M | $7.6M | +591% |
| Pre-tax earnings | $89.7M | $189M | −$99.8M | -53% |
| Other expense, net | $242M | $121M | $121M | +100% |
| Net earnings | $83.1M | $180M | −$96.6M | -54% |
| Minority interests | $3.7M | $5.2M | −$1.5M | -29% |
| Income tax | $2.8M | $4.5M | −$1.6M | -37% |
| Depreciation & amortization | $82.0M | $82.1M | −$81K | -0.1% |
| Share-based compensation | $23.7M | $9.3M | $14.4M | +155% |
| Working capital & other | $2.2M | −$44.4M | $46.6M | — |
| Operating cash flow | $191M | $227M | −$35.7M | -16% |
| Free cash flow (OCF − capex) | $166M | $205M | −$39.0M | -19% |
| Capital expenditures | $24.6M | $21.2M | $3.3M | +16% |
Questions
How much did Omega Healthcare Investors's revenue grow year over year in Q3 2026?
Omega Healthcare Investors's revenue rose $29.0M (+9%) from $312M in Q3 2025 to $341M in Q3 2026. Operating margin 97.4% against 99.6% (-2.2 pts).